REGENXBIO Inc. (Nasdaq: RGNX) highlighted progress and upcoming anticipated milestones across its pipeline of AAV gene ...
In an increasingly xenophobic country, Salt Lake City’s benevolent attitude toward immigrants is a strange anomaly. Can its ...
The Sims 4 developer Maxis reaffirms its core values in a bid to address fan concerns stemming from EA's controversial buyout ...
The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...
NASHVILLE—Something about Kyrie Irving always captivated Duke Miles. Perhaps it was his ballhandling ability or his flair for ...
Coherus Oncology formally introduces non-proprietary name: tagmokitug--Publication shows picomolar affinity for CCR8 with no off-target binding ...
In a sport that often tethers itself to history and tradition, Oregon has become a unique kind of vanguard over the past 25 ...
Pfizer Inc. and Boltz, PBC, an applied AI research lab, today announced a strategic collaboration to empower scientists ...
After testing the interest of sports fans in short-form content, Disney aims to bring brief bursts to a broader audience. The ...
Pratt has become a darling of many Republicans who have latched onto his criticism of Mayor Bass and Governor Newsom's ...
Community releases industry outlook as brands shift from one-way blasts to meaningful, two-way relationships Companies ...
Founded in 2025, DoppelIQ builds AI-powered digital consumers for B2C brands, achieving 80–95% accuracy in predicting ...